Pinealon
OtherAlso known as EDR peptide, Glu-Asp-Arg
Evidence tier
Limited published literature
22 publications over 18 years · trials not yet curated
- Researched since
- 2008
- Publications
- 22
- Mean purity
- —
- Vendors listing
- 5
No indexed vendor publishes certificate records for Pinealon that this index could read yet, so no purity comparison is possible.
Score breakdown
The score has two halves: the research base — how long the compound has been studied and how much has been published — and the quality of the evidence the market produces for it, aggregated across every vendor that carries it: assayed purity, lot-to-lot consistency, readable third-party certificates and those vendors’ review record. It measures the evidence base, not the merits or safety of the substance.
Studied since 2008 — 18 years of published research
How long the compound has been studied. Fifteen years or more of published literature earns full marks; a newer compound earns less.
22 publications indexed in PubMed
The volume of published literature located. Full marks at fifty or more publications.
No certificate records indexed yet — nothing recorded yet
Average assayed purity on the certificates published by vendors that carry this compound. Full marks at 99.5%+, nothing at 95% or below.
No certificate records indexed yet — nothing recorded yet
How tightly assayed purity and labeled-versus-actual mass hold across different lots. Rewards reproducible manufacturing.
5 of 5 listing vendors publish an accessible certificate policy
Whether the vendors carrying this compound publish per-lot certificates anyone can read without an account.
No certificate records indexed yet — nothing recorded yet
Share of certificates issued by a recognised third-party testing lab rather than an unnamed or self-named one.
What is Pinealon?
A short synthetic peptide (Glu-Asp-Arg) from the Khavinson peptide-bioregulator research programme, studied preclinically in models of oxidative stress and neuroprotection.
Studied in published research for neuroprotection and oxidative-stress models.
Regulatory status
Labeled by vendors for laboratory research use only. Not approved as a medicine in the United States, United Kingdom, or European Union.
What the research examines
The areas of published research this compound appears in. These describe what the literature has studied — never a claim of benefit, effect or suitability for any use.
Published research
PepIndex records the size and shape of the published research footprint only. It does not evaluate or summarise clinical significance, does not describe administration, and nothing here is a claim of safety or efficacy.
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions — Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews (2026)
Peer-reviewed article indexed in PubMed, published in Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews (2026).
- Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes — Rejuvenation research (2011)
Peer-reviewed article indexed in PubMed, published in Rejuvenation research (2011).
- Pinealon protects the rat offspring from prenatal hyperhomocysteinemia — International journal of clinical and experimental medicine (2012)
Peer-reviewed article indexed in PubMed, published in International journal of clinical and experimental medicine (2012).
- [Pinealon and Cortexin influence on behavior and neurochemical processes in 18-month aged rats within hypoxia and hypothermia] — Advances in gerontology = Uspekhi gerontologii (2015)
Peer-reviewed article indexed in PubMed, published in Advances in gerontology = Uspekhi gerontologii (2015).
- [EFFECT OF SYNTHETIC PEPTIDES ON AGING OF PATIENTS WITH CHRONIC POLYMORBIDITY AND ORGANIC BRAIN SYNDROME OF THE CENTRAL NERVOUS SYSTEM IN REMISSION] — Advances in gerontology = Uspekhi gerontologii (2015)
Peer-reviewed article indexed in PubMed, published in Advances in gerontology = Uspekhi gerontologii (2015).
- [Regulation of content of cytokines in blood serum and of caspase-3 activity in brains of old rats in model of sharp hypoxic hypoxia with Cortexin and Pinealon] — Advances in gerontology = Uspekhi gerontologii (2014)
Peer-reviewed article indexed in PubMed, published in Advances in gerontology = Uspekhi gerontologii (2014).
PepIndex describes what literature exists. We do not interpret it, assess clinical significance, or publish quantities, protocols or instructions for use.
Vendor comparison
| Vendor | Score here | Price / mg | Certificates | Mean purity | Label deviation | Get it |
|---|---|---|---|---|---|---|
| Protide Health | 89.994% | $3.50 (70%) | 0 | — | — | |
| Good Science Bio | 79.275% | $2.75 (55%) | 0 | — | — | |
| Ascension Peptides | 78.186% | $5.00 (100%) | 0 | — | — | |
| NeuroLabs Research | 78.186% | $5.00 (100%) | 0 | — | — | |
| Northline LabsISO/IEC 17025 | 73.393% | $8.00 (160%) | 0 | — | — |
Certificate records
No certificate records are indexed. Either none are published, or those published could not be read without an account.